首頁 > 市場調查報告書 > 食物/飲料

食品添加劑機能性食品

市場調查報告書

商品編碼

1761813

全球 CROCIN 市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global CROCIN Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年07月01日 | 出版商:

Value Market Research | 英文 152 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

預計全球 CROCIN 市場規模將從 2024 年的 57.2 億美元成長到 2033 年的 94.3 億美元，在 2026 年至 2033 年的預測期內，年複合成長率(CAGR) 將達到 5.72%。

藏紅花素市場涵蓋藥物化合物藏紅花素的生產和分銷，由於發燒和疼痛相關疾病的日益流行，該市場正在經歷顯著成長。藏紅花素以其對乙醯氨基酚為基礎的鎮痛和解熱功效而聞名，廣泛應用於家庭和醫療保健領域。隨著消費者健康意識的不斷提高，越來越多的消費者選擇使用藏紅花素等非處方藥來快速緩解常見疾病。這一趨勢推動了對藏紅花素產品的需求，為未來幾年市場強勁成長奠定了基礎。

此外，隨著消費者尋求有效解決方案來管理各種疾病相關症狀，預防性醫療保健日益受到重視，這也影響了藏紅花素 (CROCIN) 市場。尤其是在發展中地區，自我藥療的興起促進了藏紅花素及類似產品的銷售成長。由於醫療保健系統在提供及時醫療服務方面面臨挑戰，有效的非處方藥供應變得至關重要。這一趨勢促使製造商增強產品供應，專注於滿足特定消費者需求的配方，例如兒科配方和針對多種症狀的複合產品。

此外，製藥業的數位轉型正在重塑 CROCIN 市場。電商平台和遠距醫療服務讓消費者更輕鬆地在家中舒適地取得包括 Crocin 在內的藥物。這種轉變在新冠疫情之後尤其重要，疫情加速了線上醫療解決方案的普及。隨著市場的不斷發展，健康意識的增強、自我藥療的興起以及數位分銷管道的成長，這些因素共同推動了 CROCIN 市場的持續成長，滿足了消費者尋求有效緩解疼痛和發燒的多樣化需求。

我們的報告經過精心設計，旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分，以確保客戶全面了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準，將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了競爭態勢以及領先公司採用的關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場發展軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前及新興市場趨勢、技術創新以及潛在投資領域。本部分將深入探討未來市場發展與成長前景。

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第 10 章：CROCIN 公司的競爭格局

CROCIN市場競爭
合作/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
TCI Chemicals Pvt. Ltd.

公司概況
公司收入
產品
最新動態

Merck KGaA

公司概況
公司收入
產品
最新動態

GSK Plc.

公司概況
公司收入
產品
最新動態

Cayman Chemical

公司概況
公司收入
產品
最新動態

APExBIO Technology

公司概況
公司收入
產品
最新動態

Wilshire Technologies

公司概況
公司收入
產品
最新動態

Biosynth

公司概況
公司收入
產品
最新動態

Cipla Inc.

公司概況
公司收入
產品
最新動態

Novartis AG

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

Aurobindo Pharma

公司概況
公司收入
產品
最新動態

Teva Pharmaceutical Industries Ltd.

公司概況
公司收入
產品
最新動態

Mallinckrodt

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR11214564

Global CROCIN Market size is anticipated to grow from USD 5.72 Billion in 2024 to USD 9.43 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 5.72% during the forecast period of 2026 to 2033.

The CROCIN market, which encompasses the production and distribution of the pharmaceutical compound Crocin, is witnessing significant growth due to the increasing prevalence of fever and pain-related ailments. Crocin, known for its efficacy as a paracetamol-based analgesic and antipyretic, is widely used in households and healthcare settings. As awareness of health and wellness continues to rise, consumers are increasingly turning to over-the-counter medications like Crocin for quick relief from common ailments. This trend is driving demand for Crocin products, positioning the market for robust expansion in the coming years.

Moreover, the growing emphasis on preventive healthcare is influencing the CROCIN market, as consumers seek effective solutions for managing symptoms associated with various conditions. The rise of self-medication, particularly in developing regions, is contributing to increased sales of Crocin and similar products. As healthcare systems face challenges in providing timely access to medical care, the availability of effective over-the-counter medications becomes crucial. This trend is prompting manufacturers to enhance their product offerings, focusing on formulations that cater to specific consumer needs, such as pediatric formulations and combination products that address multiple symptoms.

Additionally, the digital transformation of the pharmaceutical industry is reshaping the CROCIN market. E-commerce platforms and telemedicine services are making it easier for consumers to access medications, including Crocin, from the comfort of their homes. This shift is particularly relevant in the wake of the COVID-19 pandemic, which has accelerated the adoption of online healthcare solutions. As the market continues to evolve, the combination of increasing health awareness, the rise of self-medication, and the growth of digital distribution channels positions the CROCIN market for sustained growth, meeting the diverse needs of consumers seeking effective pain and fever relief.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Application

Food
Chemical Industry
Drug
Others

By Purity

Purity >98%
Purity <98%

By Indication

Pain
Pyrexia (Fever)

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CROCIN INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Purity
- 3.7.3 Market Attractiveness Analysis By Indication
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CROCIN MARKET ANALYSIS BY APPLICATION

5.1. Overview By Application
5.2. Historical and Forecast Data Analysis By Application
5.3. Food Historic and Forecast Sales By Regions
5.4. Chemical Industry Historic and Forecast Sales By Regions
5.5. Drug Historic and Forecast Sales By Regions
5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL CROCIN MARKET ANALYSIS BY PURITY

6.1. Overview By Purity
6.2. Historical and Forecast Data Analysis By Purity
6.3. Purity >98% Historic and Forecast Sales By Regions
6.4. Purity <98% Historic and Forecast Sales By Regions

7. GLOBAL CROCIN MARKET ANALYSIS BY INDICATION

7.1. Overview By Indication
7.2. Historical and Forecast Data Analysis By Indication
7.3. Pain Historic and Forecast Sales By Regions
7.4. Pyrexia (Fever) Historic and Forecast Sales By Regions

8. GLOBAL CROCIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1. Overview By Distribution Channel
8.2. Historical and Forecast Data Analysis By Distribution Channel
8.3. Hospital Pharmacy Historic and Forecast Sales By Regions
8.4. Retail Pharmacy Historic and Forecast Sales By Regions
8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL CROCIN MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE CROCIN COMPANIES

10.1. CROCIN Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF CROCIN INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. TCI Chemicals Pvt. Ltd.
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Merck KGaA
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. GSK Plc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Cayman Chemical
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. APExBIO Technology
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Wilshire Technologies
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Biosynth
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Cipla Inc.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Novartis AG
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Sanofi
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Aurobindo Pharma
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Teva Pharmaceutical Industries Ltd.
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. Mallinckrodt
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments